Otonomy (NASDAQ:OTIC) reported quarterly losses of $(0.18) per share. This is a 5.26 percent increase over losses of $(0.19) per share from the same period last year.
Cidara Therapeutics Announces 1-For-20 Reverse Stock Split, Will Begin Trading On A Split-Adjusted Basis Commencing Upon Market Open On April 24, 2024
Cidara Therapeutics, Inc. (NASDAQ:CDTX) (the Company), a biotechnology company using its proprietary Cloudbreak® platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the
